Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587651 · ClinicalTrials.gov registry record · Phase 4
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Phase 4 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT01587651 is a Phase 4 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 110 participants.
The verdict
NCT01587651, a Phase 4 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
This is a Phase 4, multicenter, open-label (blinded Pharmacodynamic PD results), randomized, 3-arm, parallel-design study of subjects with stable Coronary Artery Disease CAD. This study will compare the PD effect of prasugrel 10 mg QD (once-daily) maintenance dose with ticagrelor 90 mg BID (twice daily) maintenance dose in subjects with stable CAD who have previously received ticagrelor loading does (LD) and maintenance dose (MD)..
Interventions
- DRUG Prasugrel Loading Dose
- DRUG Prasugrel Maintenance Dose
- DRUG Ticagrelor Maintenance Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587651
The ClinicalTrials.gov registry entry for NCT01587651 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prasugrel Loading Dose is the first listed.
NCT01587651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587651 about?
NCT01587651 is a clinical study titled "Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease". This is a Phase 4, multicenter, open-label (blinded Pharmacodynamic PD results), randomized, 3-arm, parallel-design study of subjects with stable Coronary Artery Disease CAD. This study will compare the PD effect of prasugrel 10 mg QD (once-daily) maintenance dose with ticagrelor 90 mg BID (twice da...
What is the current status of trial NCT01587651?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2012-03. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01587651?
The interventions under investigation include: Prasugrel Loading Dose (DRUG), Prasugrel Maintenance Dose (DRUG), Ticagrelor Maintenance Dose (DRUG).
Who is sponsoring clinical trial NCT01587651?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.